Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
Jharna Datta(The Ohio State University Wexner Medical Center), Sameek Roychowdhury(The Ohio State University Wexner Medical Center), Eric Samorodnitsky(The Ohio State University), Michele R. Wing(The Ohio State University), Julie W. Reeser(The Ohio State University), Jharna Miya(The Ohio State University), Elijah P. Gardner(The Ohio State University), Lianbo Yu(The Ohio State University), Hannah Parks(The Ohio State University), Senthilkumar Damodaran(The Ohio State University), Cristina Ocrainiciuc(The Ohio State University), Darshna Bhatt(The Ohio State University), John L. Hays(The Ohio State University)
Cited by 93
Related Papers
Landscape of Microsatellite Instability Across 39 Cancer Types
|JCO Precision Oncology|2017|1.5k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637